Yahoo
NYSE - Nasdaq Real Time Price USD

Nuvation Bio Inc. (NUVB)

4.1600 -0.0300 (-0.72%)
At close: November 6 at 4:00:02 PM EST
4.1900 +0.0300 (+0.72%)
After hours: November 6 at 6:45:56 PM EST
Trade NUVB on Coinbase

News headlines

Updated 32m ago
Powered by Yahoo Scout

Nuvation Bio’s Q3 2026 results showed growing IBTROZI product revenue, strong cash resources, and continued development of safusidenib. The company also advanced its Phase 3 glioma program, while investors weigh persistent operating losses, market variability, and upcoming clinical data.

All SEC Filings

10-Q : Periodic Financial Reports

November 4, 2026

8-K : Corporate Changes & Voting Matters

November 4, 2026

8-K : Corporate Changes & Voting Matters

August 6, 2026

10-Q : Periodic Financial Reports

August 6, 2026

8-K : Corporate Changes & Voting Matters

July 6, 2026

8-K : Corporate Changes & Voting Matters

June 30, 2026

8-K : Corporate Changes & Voting Matters

May 27, 2026

10-Q : Periodic Financial Reports

May 4, 2026

8-K : Corporate Changes & Voting Matters

May 4, 2026

DEFA14A : Proxy Statements

April 21, 2026

DEF 14A : Proxy Statements

April 10, 2026

ARS : Annual Report to Shareholders

April 10, 2026

S-8 : Offering Registrations

March 3, 2026

8-K : Corporate Changes & Voting Matters

March 2, 2026

10-K : Periodic Financial Reports

March 2, 2026

8-K : Corporate Changes & Voting Matters

January 12, 2026

8-K : Corporate Changes & Voting Matters

November 26, 2025

8-K : Corporate Changes & Voting Matters

November 17, 2025

8-K : Corporate Changes & Voting Matters

November 3, 2025

10-Q : Periodic Financial Reports

November 3, 2025

S-8 : Offering Registrations

November 3, 2025

8-K : Corporate Changes & Voting Matters

August 7, 2025

10-Q : Periodic Financial Reports

August 7, 2025

8-K : Corporate Changes & Voting Matters

June 11, 2025

8-K : Corporate Changes & Voting Matters

May 23, 2025

8-K : Corporate Changes & Voting Matters

May 7, 2025

10-Q : Periodic Financial Reports

May 7, 2025

ARS : Annual Report to Shareholders

April 8, 2025

DEF 14A : Proxy Statements

April 8, 2025

8-K : Corporate Changes & Voting Matters

March 25, 2025

8-K : Corporate Changes & Voting Matters

March 6, 2025

10-K : Periodic Financial Reports

March 6, 2025

8-K : Corporate Changes & Voting Matters

March 5, 2025

8-K : Corporate Changes & Voting Matters

March 4, 2025

8-K : Corporate Changes & Voting Matters

February 12, 2025

10-Q : Periodic Financial Reports

November 6, 2024

8-K : Corporate Changes & Voting Matters

November 6, 2024

8-K : Corporate Changes & Voting Matters

October 7, 2024

8-K : Corporate Changes & Voting Matters

September 5, 2024

DEFR14A : Proxy Statements

August 13, 2024

S-3 : Offering Registrations

August 5, 2024

10-Q : Periodic Financial Reports

August 5, 2024

8-K : Corporate Changes & Voting Matters

August 5, 2024

ARS : Annual Report to Shareholders

July 30, 2024

DEF 14A : Proxy Statements

July 30, 2024

PRER14A : Proxy Statements

July 16, 2024

8-K/A : Corporate Changes & Voting Matters

June 20, 2024
Mobilize your Website
View Site in Mobile | Classic
Share by: